Notes
🚨Thank you for the flow that caught my attention on $SPOT @unusual_whales
It's not just big flow that makes you loads of money!
These tiny orders caught my eye, causing me to check out the other BTO put volume coming in. I got a+1,770% gain in 2 days w/ the 575p I took🙏
Do you know that @realDonaldTrump has a Robot Dog named $Spot ? @RoboDog_Spot
CA:
4yaJWpNob51GCKRGdfczxzs5hUhy6NBdjbARxN9cpump
RECAP
• $CAVA: Q3 EPS $0.15, above expectations of $0.11; sales up 39% to $243.8M; FY guidance for restaurant comp sales at 12.5%, up from 8.5-9.5%, and EBITDA at $123M. Plans to increase restaurant openings and margins.
• $FLUT: Q3 adjusted EBITDA up 74% to $450M; revenue up 27% to $3.25B; raised full-year forecasts for EBITDA and revenue, expecting 35% profit increase.
• $CART: Q3 EPS $0.42 vs. $0.22 est.; revenue $852M vs. $844M est.; Q4 EBITDA guidance $230M-$240M, below estimate; increased buyback program by $250M.
• $LNW: Q3 net income $64M, less than $100.7M expected; revenue $817M, slightly below $821.21M; continues double-digit revenue growth.
• $RIVN: Formed JV with Volkswagen for tech development, with VW investing up to $5.8B by 2027.
• $SAVE: Shares fell -60% due to bankruptcy filing rumors, currently negotiating with creditors.
• $TSLA: Recalling 2,431 Cybertrucks due to potential power loss issues, marking the sixth recall this year.
• $MODG: Q3 EPS loss at -$0.02, better than -$0.16 expected; revenue $1.01B, above $983M forecast; adjusted full-year revenue and EBITDA guidance downwards.
• $OXY: Q3 adj EPS $1.00, above $0.74 expected; production rose 15.7% to 1.41 Mboepd due to CrownRock acquisition, despite lower prices; Q4 production expected at 1.43-1.47 Mboepd.
• $RKLB: Q3 EPS ($0.10) vs. ($0.11) est., with revenues at $104.8M vs. $102.3M est.; Q4 revenue guidance $125-135M, with a new multi-launch deal for Neutron.
• $DHT: Q3 EPS $0.22, topping $0.20 estimate; adjusted EBITDA $70.4M vs. $66.4M expected, on slightly lower than expected adjusted revenues of $92.64M.
• $AB): Reported a 2% drop in AUM to $793B in October 2024 from $806B due to market downturn, with no net inflows or outflows.
• $MARA: Q3 revenue increased by 34% to $131.6M, missing the forecast of $137.5M.
• $PAY: Q3 EPS was $0.15 compared to $0.09 expected; revenue hit $231.6M against $190.6M estimated. They foresee Q4 revenue at $215M-$220M and FY24 at $829M-$834M, both above consensus.
• $RKT: Q3 adjusted EPS met estimates at $0.08; adjusted EBITDA was $286M, above the $272.33M expected, with revenues at $1.323B, beating the forecast. They anticipate a drop in Q4 revenue to $1.05-1.2B.
• $WULF: Q3 adjusted EBITDA was $6M, below the $11.2M prediction, with revenues at $27.1M, not meeting the $34.28M estimate.
• $AMGN: Clarified no link between MariTide use and bone density changes, despite earlier reports of potential loss. The company remains confident in the drug's future.
• $ICUI: Q3 adjusted EPS $1.59 vs $1.25 expected; revenue $589.131M vs $574.7M forecast, with a gross margin of 34.8%. FY guidance raised for EPS and EBITDA.
• $NTRA: Q3 EPS ($0.26) vs ($0.57) expected, revenue $439.8M vs $361.45M; FY revenue guidance set at $1.61-1.64B, above consensus.
• $PGNY: Q3 EPS $0.11, below $0.13 expected; revenue $286.625M vs $296.88M; full-year revenue and EBITDA guidance below market expectations.
• $SGMO: Q3 EPS $0.04, better than ($0.03) expected; revenue $49.41M vs $17.94M forecast. Adjusted annual operating expenses expected to be $125-145M.
• $SYRS: Shares dropped -80% after the SELECT-MDS-1 trial for tamibarotene failed to meet its primary endpoint, leading to discontinuation of the study.
• $DOX: Q4 adjusted EPS $1.70, matching expectations, with revenue at $1.264B, slightly above the $1.263B estimate.
• $PLUS: Q2 adjusted EPS $1.36, below $1.39 expected; revenue $515.2M vs $576.5M forecast. Full-year sales guidance unchanged, but adjusted EBITDA expected at $195-205M.
• $IAS: Q3 EPS $0.10 vs $0.07 expected, with revenue at $133.528M and a gross margin of 80%. Q4 revenue and EBITDA guidance were both below expectations.
• $SOUN: Q3 adjusted EPS ($0.04) vs ($0.07) expected; revenue $25.1M, above $23.02M estimate. Set FY24 and FY25 revenue targets.
• $SWKS: Q4 adjusted EPS $1.55 vs $1.52, revenue $1.025B, nearly matching estimates. Q1 guidance for revenue and EPS below expectations.
• $SPOT: Q3 revenue growth of 19% to €3.99B missed the €4.02B estimate; profit margin improved. Q4 revenue guidance below expectations but operating income and MAUs on target.
• $SMCI: Announced delay in filing Q3 2024 quarterly report due to ongoing issues with the annual report.
• $ZI: Q3 adjusted EPS $0.28, surpassing the $0.22 estimate; revenue $303.6M vs $299.38M. Q4 revenue guidance in line with estimates, but EPS slightly below consensus.
#Downgrades - Nov 13, 2024
• $AE: B.Riley Downgrades to Neutral from Buy - PT $38 (from $45)
• $ANGI: Goldman Sachs Downgrades to Neutral from Buy - PT $2.50 (from $3.25)
• $ANGI: Citi Downgrades to Neutral from Buy - PT $2 (from $3.25)
• $ARCH: Jefferies Downgrades to Hold from Buy - PT $165 (from $155)
• $BCAB: H.C. Wainwright Downgrades to Neutral from Buy
• $CAT: Evercore ISI Downgrades to Underperform from In Line - PT $365 (from $321)
• $CCLD: Roth/MKM Downgrades to Neutral from Buy - PT $3.50 (from $5)
• $COTY: TD Cowen Downgrades to Hold from Buy - PT $8.50 (from $11)
• $CPT: Stifel Downgrades to Hold from Buy - PT $121 (from $120)
• $DOCS: Canaccord Genuity Downgrades to Hold from Buy - PT $60 (from $40)
• $ESAB: Evercore ISI Downgrades to Underperform from In Line - PT $122 (from $102)
• $ETN: Evercore ISI Downgrades to In Line from Outperform - PT $389 (from $333)
• $IP: BNP Paribas Downgrades to Underperform from Neutral - PT $48.20
• $ITW: Evercore ISI Downgrades to Underperform from In Line - PT $255 (from $246)
• $MASS: Leerink Partners Downgrades to Market Perform from Outperform - PT $4
• $PGNY: Truist Securities Downgrades to Hold from Buy - PT $19 (from $26)
• $RAPT: Stifel Downgrades to Hold from Buy - PT $2 (from $7)
• $SBUX: Redburn-Atlantic Downgrades to Sell from Neutral - PT $77 (from $84)
• $SHOP: ATB Capital Markets Downgrades to Sector Perform from Outperform
• $SOUN: Ladenburg Downgrades to Neutral from Buy - PT $7
• $SPOT: Phillip Securities Downgrades to Accumulate from Buy - PT $485 (from $420)
• $SVRA: Evercore ISI Downgrades to In Line from Outperform - PT $5 (from $7)
• $SYRS: Brookline Capital Markets Downgrades to Hold from Buy
• $SYRS: H.C. Wainwright Downgrades at Neutral from Buy - PT $1 (from $6)
• $SYRS: JMP Securities Downgrades to Market Perform from Outperform
• $SYRS: TD Cowen Downgrades to Hold from Buy
• $TNK: BofA Securities Downgrades to Underperform from Neutral - PT $46 (from $51)
• $WMS: Stephens Downgrades to Equal Weight from Overweight - PT $135
$EEFI flywheel is getting started. No mentions on timeline yet.
Study the mechanics
Study inflation resistant stable coins
Study @asymmetryfin
Study the backers
And u will understand why.
$SPOT & $AMPL
If u wonder why $EEFI is going up, read this. Its all maths. Current Ampl price 1.31.
👇🏻
Seems like the flywheel is getting started for $EEFI and people try to front run the inevitable pump once $AMPL truly takes off.
Big wallets buying in already:
0x49Ec0bb2272E77Be9c3295C9fc12EF989696F590
Personally, @base has been one of the most dissapointing executions ever.
One of the most anticipated launches failed (FT). Farcaster is the only one in crypto space to compete with web2 social platforms though.
Low-tier memes where they just put 'blue' versions on whatever mascot (talking about base native memes).
Not supporting legit projects by listing / endorsing at official twitter. Only with Miggles? Lol. No DeFi / utility etc. Why not supporting $SPOT as a stable coin currency for example?
Failed marketing where they just try to extract attention from @jessepollak.
I am going to give it some time and if no substantial change, will see it as a loss and move on.
Hopefully this tweet will mark the bottom.
Nothing changed for me. Still holding these. Time will tell.
Great developments for all of them:
$FP: Gameplay 2.0 end of month, airdrop & referreal campaign soon, base smart wallet release, metrics up price oversold. Actively playing myself too, its really good.
$PEAS: LVF being audited, expecting utility coins to make a come back.
$EEFI: $AMPL / $SPOT getting traction, Brian Armstrong publicly shilling.
#PEPECOIN / #BasedAI: currently cyanet testnet, mainnet soon with release of the brains.
$QUIL: 2.0 release expected July 20th. Smart contract release.
$NPC: Massive run, now consolidating, Elon tweeted about NPC this week 3 times. Political debates heating up. A lot of things happening in the back ground too.
https://t.co/U3Mf2vDjLe
